Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations. Review uri icon

Overview

abstract

  • All patients with acute coronary syndromes and without obvious bleeding or acute cerebrovascular events are candidates for heparin therapy. This article is a review of the pharmacology of unfractionated and low-molecular-weight heparins, trials of heparin therapy in acute coronary syndromes, and recommendations for using these agents.

publication date

  • January 1, 2000

Research

keywords

  • Anticoagulants
  • Coronary Disease
  • Fibrinolytic Agents
  • Heparin
  • Heparin, Low-Molecular-Weight
  • Myocardial Infarction

Identity

Scopus Document Identifier

  • 0033958302

PubMed ID

  • 10645678

Additional Document Info

volume

  • 67

issue

  • 1